Literature DB >> 17540850

Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients.

Lisette Okkels Jensen1, Per Thayssen, Gary S Mintz, Michael Maeng, Anders Junker, Anders Galloe, Evald Hoej Christiansen, Soeren K S Hoffmann, Knud Erik Pedersen, Henrik Steen Hansen, Knud Noerregaard Hansen.   

Abstract

AIMS: Intravascular ultrasound (IVUS) assesses arterial remodelling by comparing the lesion external elastic membrane (EEM) with the reference segments; however, reference segments are rarely disease-free. The aim was to assess lesion and reference segment remodelling and plaque burden in patients with type-2 diabetes mellitus. METHODS AND
RESULTS: We used pre-intervention IVUS to study 62 de novo lesions in 43 patients with type-2 diabetes mellitus. The lesion site was the image slice with the smallest lumen cross-sectional area (CSA). The proximal and distal reference segments were the most normal-looking segments within 5 mm proximal and distal to the lesion. Plaque burden was measured as plaque CSA/EEM CSA. The remodelling index was defined as lesion EEM CSA/mean reference EEM CSA. Reference segment plaque burden measured 0.54 +/- 0.09. The majority of lesions (83.9%) had negative remodelling (lesion EEM < reference). Similarly, the slope of the regression line relating EEM to plaque CSA within the lesion was less than the reference substantiating negative remodelling. The reference segment plaque burden correlated inversely with the difference between IVUS lumen and quantitative coronary angiographic artery size [slope = -0.12 (95% CI -0.17 to -0.07); P < 0.001] in all patients with type-2 diabetes mellitus.
CONCLUSION: Lesions in type-2 diabetic patients are different from previous reports in non-diabetics. Lesions in type-2 diabetics are characterized by a large reference segment plaque burden and negative lesion site remodelling. These IVUS findings may explain the angiographic appearance of small arteries in diabetic patients.

Entities:  

Mesh:

Year:  2007        PMID: 17540850     DOI: 10.1093/eurheartj/ehm175

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Effect of statin on the reference segments after bare-metal stent implantation.

Authors:  Byeong-Keuk Kim; Myeong-Ki Hong
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

2.  Glycaemic status influences the nature and severity of coronary artery disease.

Authors:  C Berry; S Noble; J C Grégoire; R Ibrahim; S Levesquie; M-A Lavoie; P L L'Allier; J-C Tardif
Journal:  Diabetologia       Date:  2010-01-14       Impact factor: 10.122

3.  Relationship between hemoglobin A1C and characteristics of plaque vulnerability in stable coronary disease: an optical coherence tomography study.

Authors:  Hiroki Ueyama; Keisuke Yasumura; Naotaka Okamoto; Yuliya Vengrenyuk; Nitin Barman; Benjamin Benhuri; Vishal Kapur; Choudhury Hasan; Joseph Sweeny; Samin K Sharma; Jagat Narula; Annapoorna S Kini; Usman Baber
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-05       Impact factor: 2.357

4.  Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound.

Authors:  Gabija Pundziute; Joanne D Schuijf; J Wouter Jukema; Jacob M van Werkhoven; Gaetano Nucifora; Isabel Decramer; Giovanna Sarno; Piet K Vanhoenacker; Johannes H C Reiber; William Wijns; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2009-05-13       Impact factor: 5.952

5.  Coronary Atherosclerotic Plaque Vulnerability Rather than Stenosis Predisposes to Non-ST Elevation Acute Coronary Syndromes.

Authors:  Mohamed Laimoud; Farouk Faris; Helmy Elghawaby
Journal:  Cardiol Res Pract       Date:  2019-03-11       Impact factor: 1.866

6.  In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes.

Authors:  Ganesh Paramasivam; Tom Devasia; Ashwal Jayaram; Abdul Razak U K; M Sudhakar Rao; Rajesh Vijayvergiya; Krishnananda Nayak
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

7.  Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis.

Authors:  Pilar Jiménez-Quevedo; Nobuaki Suzuki; Cecilia Corros; Cruz Ferrer; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Camino Bañuelos; Javier Escaned; Cristina Fernández; Marco Costa; Carlos Macaya; Theodore Bass; Manel Sabaté
Journal:  Diabetes       Date:  2008-10-01       Impact factor: 9.461

8.  No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.

Authors:  Lasse Bach Steffensen; Søren Feddersen; Simone Rørdam Preil; Lars Melholt Rasmussen
Journal:  Cardiovasc Diabetol       Date:  2018-05-17       Impact factor: 9.951

9.  Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.

Authors:  Run Du; Rui Yan Zhang; Lin Lu; Ying Shen; Li Jin Pu; Zheng Bin Zhu; Qi Zhang; Jian Hu; Zhen Kun Yang; Feng Hua Ding; Jian Sheng Zhang; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-11-27       Impact factor: 9.951

10.  Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes.

Authors:  Mohamed Laimoud; Farouk Faris; Helmy Elghawaby
Journal:  Egypt Heart J       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.